13G Filing: Aisling Capital IV, LP and GTx Inc (GTXI)

Page 7 of 11

Page 7 of 11 – SEC Filing

CUSIP No.  40052B 20 7
SCHEDULE 13G
Page 7 of 12
ITEM 1.
(a)
Name of Issuer:
GTx, Inc. (the “Issuer”)
(b)
Address of Issuer’s Principal Executive Offices:
175 Toyota Plaza, 7th Floor, Memphis, Tennessee 38103
ITEM 2.
(a)
Name of Person Filing:
This Schedule 13G (this “Statement”) is being filed by the following persons (collectively, the “Reporting Persons”):
(i)
Aisling Capital IV, LP, a Delaware limited partnership (Aisling);
(ii)
Aisling Capital Partners IV, LP, a Delaware limited partnership (Aisling Partners), a general partner of Aisling;
(iii)
Aisling Capital Partners IV LLC, a Delaware limited liability company (Aisling Partners GP), a general partner of Aisling Partners;
(iv)
Mr. Steve Elms, a managing member of Aisling Partners GP;
(v)
Mr. Andrew Schiff, a managing member of Aisling Partners GP.
(b)
Address of Principal Business Office, or if None, Residence:
The address of the principal business offices of each of the Reporting Persons is 888 Seventh Avenue, 12th Floor, New York, New York 10106.
(c)
Citizenship:
(i)        Aisling – a Delaware limited partnership
(ii)       Aisling Partners – a Delaware limited partnership
(iii)      Aisling Partners GP – a Delaware limited liability company
(iv)      Mr. Elms – United States
(v)       Mr. Schiff – United States
(d)
Title of Class of Securities:
Common Stock, par value $0.001 per share (the “Common Stock”).
(e)
CUSIP Number:
40052B 20 7
ITEM 3.
IF THIS STATEMENT IS FILED PURSUANT TO §240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A:
(a)
[__]  Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o)
(b)
[__]  Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c)
(c)
[__]  Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c)
(d)
[__]  Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8)
(e)
[__]  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E)
(f)
[__]  An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
(g)
[__]  A Parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
(h)
[__]  A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813)
(i)
[__]  A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3)
(j)
[__]  A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
(k)
[__]  Group, in accordance with §240.13d-1(b)(1)(ii)(J).

Follow Oncternal Therapeutics Inc. (NASDAQ:ONCT)

Page 7 of 11